PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of eidLink to Publisher's site
 
Emerg Infect Dis. 2001 Jan-Feb; 7(1): 43–48.
PMCID: PMC2631670
Transferable plasmid-mediated resistance to streptomycin in a clinical isolate of Yersinia pestis.
A. Guiyoule, G. Gerbaud, C. Buchrieser, M. Galimand, L. Rahalison, S. Chanteau, P. Courvalin, and E. Carniel
Laboratoire des Yersinia, Institut Pasteur, 28 rue du Dr. Roux, 75724 Paris, France.
Abstract
Plasmid-mediated high-level resistance to multiple antibiotics was reported in a clinical isolate of Yersinia pestis in Madagascar in 1997. We describe a second Y. pestis strain with high-level resistance to streptomycin, isolated from a human case of bubonic plague in Madagascar. The resistance determinants were carried by a self-transferable plasmid that could conjugate at high frequencies to other Y. pestis isolates. The plasmid and the host bacterium were different from those previously associated with multiple-drug resistance, indicating that acquisition of resistance plasmids is occurring in this bacterial species. Emergence of resistance to streptomycin in Y. pestis represents a critical public health problem since this antibiotic is used as the first-line treatment against plague in many countries.
Full Text
The Full Text of this article is available as a PDF (101K).
Articles from Emerging Infectious Diseases are provided here courtesy of
Centers for Disease Control and Prevention